209 related articles for article (PubMed ID: 28581764)
1. Tumor-Targeted and Clearable Human Protein-Based MRI Nanoprobes.
Zhao Y; Peng J; Li J; Huang L; Yang J; Huang K; Li H; Jiang N; Zheng S; Zhang X; Niu Y; Han G
Nano Lett; 2017 Jul; 17(7):4096-4100. PubMed ID: 28581764
[TBL] [Abstract][Full Text] [Related]
2. Transferrin-coated gadolinium nanoparticles as MRI contrast agent.
Korkusuz H; Ulbrich K; Welzel K; Koeberle V; Watcharin W; Bahr U; Chernikov V; Knobloch T; Petersen S; Huebner F; Ackermann H; Gelperina S; Kromen W; Hammerstingl R; Haupenthal J; Gruenwald F; Fiehler J; Zeuzem S; Kreuter J; Vogl TJ; Piiper A
Mol Imaging Biol; 2013 Apr; 15(2):148-54. PubMed ID: 22811020
[TBL] [Abstract][Full Text] [Related]
3. Self-Assembled Nanomicelles as MRI Blood-Pool Contrast Agent.
Babič A; Vorobiev V; Xayaphoummine C; Lapicorey G; Chauvin AS; Helm L; Allémann E
Chemistry; 2018 Jan; 24(6):1348-1357. PubMed ID: 29120077
[TBL] [Abstract][Full Text] [Related]
4. Gd-encapsulated carbonaceous dots with efficient renal clearance for magnetic resonance imaging.
Chen H; Wang GD; Tang W; Todd T; Zhen Z; Tsang C; Hekmatyar K; Cowger T; Hubbard R; Zhang W; Stickney J; Shen B; Xie J
Adv Mater; 2014 Oct; 26(39):6761-6766. PubMed ID: 25178894
[TBL] [Abstract][Full Text] [Related]
5. Zwitterionic Gadolinium(III)-Complexed Dendrimer-Entrapped Gold Nanoparticles for Enhanced Computed Tomography/Magnetic Resonance Imaging of Lung Cancer Metastasis.
Liu J; Xiong Z; Zhang J; Peng C; Klajnert-Maculewicz B; Shen M; Shi X
ACS Appl Mater Interfaces; 2019 May; 11(17):15212-15221. PubMed ID: 30964632
[TBL] [Abstract][Full Text] [Related]
6. Gadolinium-conjugated PLA-PEG nanoparticles as liver targeted molecular MRI contrast agent.
Chen Z; Yu D; Liu C; Yang X; Zhang N; Ma C; Song J; Lu Z
J Drug Target; 2011 Sep; 19(8):657-65. PubMed ID: 21091273
[TBL] [Abstract][Full Text] [Related]
7. Targeted dual-contrast T1- and T2-weighted magnetic resonance imaging of tumors using multifunctional gadolinium-labeled superparamagnetic iron oxide nanoparticles.
Yang H; Zhuang Y; Sun Y; Dai A; Shi X; Wu D; Li F; Hu H; Yang S
Biomaterials; 2011 Jul; 32(20):4584-93. PubMed ID: 21458063
[TBL] [Abstract][Full Text] [Related]
8. A cation exchange strategy to construct a targeting nanoprobe for enhanced
Chen S; Zhang Q; Sun H; Zheng Y; Chen Q; Luo Y; Chen H; Zhou Q
J Mater Chem B; 2020 Sep; 8(37):8519-8526. PubMed ID: 32812623
[TBL] [Abstract][Full Text] [Related]
9. Gold nanoparticles functionalised with fast water exchanging Gd3+ chelates: linker effects on the relaxivity.
Ferreira MF; Gonçalves J; Mousavi B; Prata MI; Rodrigues SP; Calle D; López-Larrubia P; Cerdan S; Rodrigues TB; Ferreira PM; Helm L; Martins JA; Geraldes CF
Dalton Trans; 2015 Mar; 44(9):4016-31. PubMed ID: 25611006
[TBL] [Abstract][Full Text] [Related]
10. Facile Synthesis of Gadolinium Chelate-Conjugated Polymer Nanoparticles for Fluorescence/Magnetic Resonance Dual-Modal Imaging.
Pan Y; Chen W; Yang J; Zheng J; Yang M; Yi C
Anal Chem; 2018 Feb; 90(3):1992-2000. PubMed ID: 29293314
[TBL] [Abstract][Full Text] [Related]
11. Toxicity evaluation of Gd2O3@SiO2 nanoparticles prepared by laser ablation in liquid as MRI contrast agents in vivo.
Tian X; Yang F; Yang C; Peng Y; Chen D; Zhu J; He F; Li L; Chen X
Int J Nanomedicine; 2014; 9():4043-53. PubMed ID: 25187708
[TBL] [Abstract][Full Text] [Related]
12. Detection of hepatocellular carcinoma in transgenic mice by Gd-DTPA- and rhodamine 123-conjugated human serum albumin nanoparticles in T1 magnetic resonance imaging.
Watcharin W; Schmithals C; Pleli T; Köberle V; Korkusuz H; Hübner F; Waidmann O; Zeuzem S; Korf HW; Terfort A; Gelperina S; Vogl TJ; Kreuter J; Piiper A
J Control Release; 2015 Feb; 199():63-71. PubMed ID: 25499552
[TBL] [Abstract][Full Text] [Related]
13. Fabrication and evaluation of tumor-targeted positive MRI contrast agent based on ultrasmall MnO nanoparticles.
Huang H; Yue T; Xu K; Golzarian J; Yu J; Huang J
Colloids Surf B Biointerfaces; 2015 Jul; 131():148-54. PubMed ID: 25982318
[TBL] [Abstract][Full Text] [Related]
14. Gadolinium as an MRI contrast agent.
Kim HK; Lee GH; Chang Y
Future Med Chem; 2018 Mar; 10(6):639-661. PubMed ID: 29412006
[TBL] [Abstract][Full Text] [Related]
15. Paramagnetic ultrasmall gadolinium oxide nanoparticles as advanced T1 MRI contrast agent: account for large longitudinal relaxivity, optimal particle diameter, and in vivo T1 MR images.
Park JY; Baek MJ; Choi ES; Woo S; Kim JH; Kim TJ; Jung JC; Chae KS; Chang Y; Lee GH
ACS Nano; 2009 Nov; 3(11):3663-9. PubMed ID: 19835389
[TBL] [Abstract][Full Text] [Related]
16. Microfluidic Synthesis of Gd-Based Nanoparticles for Fast and Ultralong MRI Signals in the Solid Tumor.
Li X; Feng Q; Jiang X
Adv Healthc Mater; 2019 Oct; 8(20):e1900672. PubMed ID: 31529786
[TBL] [Abstract][Full Text] [Related]
17. Tumor-specific design of PEGylated gadolinium-based nanoscale particles: Facile synthesis, characterization, and improved magnetic resonance imaging of metastasis lung cancer.
Sui Y; Li Y; Li Y; Jin H; Zheng Y; Huang W; Chen S
J Photochem Photobiol B; 2020 Jan; 202():111669. PubMed ID: 31739258
[TBL] [Abstract][Full Text] [Related]
18. Ultrasensitive MRI detection of spontaneous pancreatic tumors with nanocage-based targeted contrast agent.
Kawano T; Murata M; Kang JH; Piao JS; Narahara S; Hyodo F; Hamano N; Guo J; Oguri S; Ohuchida K; Hashizume M
Biomaterials; 2018 Jan; 152():37-46. PubMed ID: 29107217
[TBL] [Abstract][Full Text] [Related]
19. Protein-targeted gadolinium-based magnetic resonance imaging (MRI) contrast agents: design and mechanism of action.
Caravan P
Acc Chem Res; 2009 Jul; 42(7):851-62. PubMed ID: 19222207
[TBL] [Abstract][Full Text] [Related]
20. Selective anchoring of Gd(III) chelates on the external surface of organo-modified mesoporous silica nanoparticles: a new chemical strategy to enhance relaxivity.
Carniato F; Tei L; Arrais A; Marchese L; Botta M
Chemistry; 2013 Jan; 19(4):1421-8. PubMed ID: 23233428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
